The mission of the Duke Division of Hematologic Malignancies and Cellular Therapy is to promote health and improve lives by preventing, diagnosing, and treating blood cancer and other life threatening diseases through integrated, innovative, and holistic patient care, education, and research.

Excellence in Patient Care

Our faculty provide comprehensive, multidisciplinary care for patients with hematologic malignancies at the Duke Cancer Center and the Duke Adult Blood & Marrow Transplant Clinic.

Learn more

Excellence in Research

The Duke Hematologic Malignancies and Cellular Therapy (HMCT) Program is a multidisciplinary basic, translational, and clinical research program whose overall goal is to improve outcomes for patients with hematologic malignancies. 

Learn more

Train with us

The Hematology-Oncology Fellowship program provides clinical and laboratory training in hematology, medical oncology, and bone marrow transplantation.

Learn more

Latest News

News
Friday, October 29, 2021
News
Friday, September 17, 2021
News
Tuesday, September 14, 2021
News
Friday, August 20, 2021

Upcoming Events

Event
 - Hematologic Malignancies and Cellular Therapy

HM Grand Rounds

December 3, 2021 - 8:30am
Dr. Andrea Sitlinger
Event
 - Hematologic Malignancies and Cellular Therapy

HM Grand Rounds

December 17, 2021 - 8:30am
Dr. Louis Diehl
Event
 - Hematologic Malignancies and Cellular Therapy

HM Grand Rounds

January 7, 2022 - 8:30am
Dr. Danielle Brander